2 Conferences Are Going Virtual This Month – One On Cannabis And Another Life Sciences

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
The coronavirus pandemic has made this an interesting time for the cannabis and life sciences industries.

In cannabis, the pandemic is thought to be a major reason why the industry is seeing record sales. U.S. cannabis sales in 2020 have already surpassed 2019’s record total as the country’s most mature markets—California, Colorado, and Oregon—have all reported record monthly sales this summer. And north of the border, Canada has opened 431 retail cannabis stores this year despite the continued presence of the virus.

On the life sciences front, most of the world’s attention (perhaps rightly) has turned to the development of a vaccine for COVID-19, putting the industry squarely in the spotlight and causing investors to flock to the sector in both the public and private markets.

For interested investors, 25 companies in either the cannabis and life sciences industries have been announced as presenters at a pair of virtual conferences happening this month: the KCSA Cannabis Investor Conference on Sept. 10 and the Virtual Life Sciences Investor Forum Sept. 17.

On the cannabis front, the group of presenters includes companies involved in flower cultivation, pharmaceutical research and CBD production. Meanwhile, presenting life sciences companies run the spectrum from those exploring neuro spinal surgical devices, clinical diagnostic tools as well as several firms involved in COVID-19 research.

A schedule for each conference agenda is below, although changes and additions are anticipated and investors are encouraged to check the Virtual Life Sciences Investor Forum schedule as the event approaches.

KCSA Cannabis Investor Conference - 9/10

11:00 AM ET FinCanna Capital Corp. FNNZF | CALI
Speaker: Andriyko Herchak, CEO & Director

11:30 AM ET Aleafia Health Inc. ALEAF | AH
Speaker: Geoffrey Benic, Chief Executive Officer

12:00 PM ET 4Front Ventures Corp. FFNTF | FFNT
Speaker: Andrew Thut, Chief Investment Officer

12:30 PM ET MariMed Inc. MRMD
Speaker: Robert Fireman, Founder & CEO

1:00 PM ET The Valens Company VLNCF | VLNS
Speaker: Everett Knight, Executive VP, Corporate Development & Capital Markets

1:30 PM ET Driven Deliveries, Inc. DRVD
Speaker: Christian Schenk, Chairman & CEO

2:00 PM ET Nextleaf Solutions Ltd. OILFF | OILS
Speaker: Charles Ackerman, CFO & Director

2:30 PM ET Clever Leaves/Schultze Special Purpose Acquisition Corp.  SAMA 
Speakers: Gary  Julien EVP and Director, SAMA; Kyle Detwiler, CEO of Clever Leaves

3:00 PM ET Blueberries Medical Co. BBRRF | BBM
Speaker: Camilo Villalba, Co-founder and CEO

3:30 PM ET Gage Cannabis Co. (Private Company)
Speakers: Fabian Monaco, President;  Bruce Linton, Executive Chairman

4:00 PM ET Experion Holdings Ltd EXPFF | EXP
Speaker: Jarrett Malnarich, Chief Executive Officer

4:30 PM ET Khiron Life Sciences Corp. KHRNF | KHRN | (Frankfurt: A2JMZC)
Speakers: Alvaro Torres, CEO; Chris Naprawa, Chairman

Virtual Life Sciences Investor Forum - 9/17

Schedule as of 9/8

10:00 AM ET VolitionRx Limited VNRX
Speakers: Cameron Reynolds, CEO; Scott Powell, EVP Investor Relations

10:30 AM ET KemPharm, Inc. KMPH
Speaker: Travis C. Mickle, Ph.D., President, Chief Executive Officer and Chairman of the Board

11:00 AM ET Assure Holdings Corp. ARHH | IOM
Speaker: John Farlinger, Executive Chairman and CEO

11:30 AM ET aTyr Pharma, Inc. LIFE
Speaker: Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer

12:00 PM ET SWK Holdings, Inc SWKH
Speaker: Winston Black, Chairman and Chief Executive Officer

12:30 PM ET Cardiol Therapeutics Inc. CRTPF | CRDL
Speaker: David Elsley, President and CEO

1:00 PM ET XPhyto Therapeutics Corp. XPHYF | XPHY4XT)

1:30 PM ET Nuvo Pharmaceuticals Inc. NRIFF | NRI
Speakers: Jesse Ledger, President & Chief Executive Officer; Kelly Demerino, Interim CFO

2:00 PM ET Salarius Pharmaceuticals, Inc. SLRX
Speaker: David Arthur, CEO

2:30 PM ET Willow Biosciences Inc. CANSF | WLLW
Speaker: Trevor Peters, President & CEO

3:00 PM ET Medipharm Labs Corp. MEDIF | LABS | MLZ
Speakers: Pat McCutcheon, CEO and Chairman; Laura Lepore, VP, IR and Communications

3:30 Caladrius Biosciences, Inc. CLBS
Speaker: David J. Mazzo, Ph.D., President & CEO

4:00 PM ET Kineta Inc. (Private Company)
Speaker: Dr. Shawn Iadonato, Chief Executive Officer

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.